BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28074629)

  • 1. A comparison of approaches for stratifying on the propensity score to reduce bias.
    Linden A
    J Eval Clin Pract; 2017 Aug; 23(4):690-696. PubMed ID: 28074629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating treatment effectiveness in patient subgroups: a comparison of propensity score methods with an automated matching approach.
    Radice R; Ramsahai R; Grieve R; Kreif N; Sadique Z; Sekhon JS
    Int J Biostat; 2012 Aug; 8(1):25. PubMed ID: 22944721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving causal inference with a doubly robust estimator that combines propensity score stratification and weighting.
    Linden A
    J Eval Clin Pract; 2017 Aug; 23(4):697-702. PubMed ID: 28116816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using classification tree analysis to generate propensity score weights.
    Linden A; Yarnold PR
    J Eval Clin Pract; 2017 Aug; 23(4):703-712. PubMed ID: 28371206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The performance of different propensity score methods for estimating marginal hazard ratios.
    Austin PC
    Stat Med; 2013 Jul; 32(16):2837-49. PubMed ID: 23239115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The performance of inverse probability of treatment weighting and full matching on the propensity score in the presence of model misspecification when estimating the effect of treatment on survival outcomes.
    Austin PC; Stuart EA
    Stat Methods Med Res; 2017 Aug; 26(4):1654-1670. PubMed ID: 25934643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bias associated with using the estimated propensity score as a regression covariate.
    Hade EM; Lu B
    Stat Med; 2014 Jan; 33(1):74-87. PubMed ID: 23787715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for estimating subgroup effects in cost-effectiveness analyses that use observational data.
    Kreif N; Grieve R; Radice R; Sadique Z; Ramsahai R; Sekhon JS
    Med Decis Making; 2012; 32(6):750-63. PubMed ID: 22691446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addressing substantial covariate imbalance with propensity score stratification and balancing weights: connections and recommendations.
    Thomas LE; Thomas SM; Li F; Matsouaka RA
    Epidemiol Methods; 2023 Jan; 12(1):20220131. PubMed ID: 38013684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reporting of covariate selection and balance assessment in propensity score analysis is suboptimal: a systematic review.
    Ali MS; Groenwold RH; Belitser SV; Pestman WR; Hoes AW; Roes KC; Boer Ad; Klungel OH
    J Clin Epidemiol; 2015 Feb; 68(2):112-21. PubMed ID: 25433444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance evaluation of regression splines for propensity score adjustment in post-market safety analysis with multiple treatments.
    Tian Y; Baro E; Zhang R
    J Biopharm Stat; 2019; 29(5):810-821. PubMed ID: 31502924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misuse of Regression Adjustment for Additional Confounders Following Insufficient Propensity Score Balancing.
    Shinozaki T; Nojima M
    Epidemiology; 2019 Jul; 30(4):541-548. PubMed ID: 31166216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies.
    Austin PC; Stuart EA
    Stat Med; 2015 Dec; 34(28):3661-79. PubMed ID: 26238958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propensity score analysis with partially observed covariates: How should multiple imputation be used?
    Leyrat C; Seaman SR; White IR; Douglas I; Smeeth L; Kim J; Resche-Rigon M; Carpenter JR; Williamson EJ
    Stat Methods Med Res; 2019 Jan; 28(1):3-19. PubMed ID: 28573919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical power in parallel group point exposure studies with time-to-event outcomes: an empirical comparison of the performance of randomized controlled trials and the inverse probability of treatment weighting (IPTW) approach.
    Austin PC; Schuster T; Platt RW
    BMC Med Res Methodol; 2015 Oct; 15():87. PubMed ID: 26472109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the use of propensity scores in case of rare exposure.
    Hajage D; Tubach F; Steg PG; Bhatt DL; De Rycke Y
    BMC Med Res Methodol; 2016 Mar; 16():38. PubMed ID: 27036963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On variance estimate for covariate adjustment by propensity score analysis.
    Zou B; Zou F; Shuster JJ; Tighe PJ; Koch GG; Zhou H
    Stat Med; 2016 Sep; 35(20):3537-48. PubMed ID: 26999553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The performance of different propensity score methods for estimating absolute effects of treatments on survival outcomes: A simulation study.
    Austin PC; Schuster T
    Stat Methods Med Res; 2016 Oct; 25(5):2214-2237. PubMed ID: 24463885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Do Propensity Score Methods Measure Up in the Presence of Measurement Error? A Monte Carlo Study.
    Rodríguez De Gil P; Bellara AP; Lanehart RE; Lee RS; Kim ES; Kromrey JD
    Multivariate Behav Res; 2015; 50(5):520-32. PubMed ID: 26610250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two propensity score-based methods for balancing covariates: the overlap weighting and fine stratification methods in real-world claims data.
    Wan W; Murugesan M; Nocon RS; Bolton J; Konetzka RT; Chin MH; Huang ES
    BMC Med Res Methodol; 2024 Jun; 24(1):122. PubMed ID: 38831393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.